免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

EchoNext

K号: K260332 · 2026-06-08

申请人Pathwai, Inc.
决定日期2026-06-08
产品代码QXO
咨询委员会CV 请注意,由于原文未提供具体内容,以下是一个示例翻译: --- 产品名称:[产品名称] 公司名称:[公司名称] FDA批准号:[FDA批准号] 510(k)申请号:[510(k)申请号] PMA申请号:[PMA申请号] 临床试验注册号:[NCT] PubMed ID:[PMID] 产品标识符:[标识符] 产品URL:[URL] --- 请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。
决定实质等同

器械摘要

EchoNext is the device name listed in this FDA 510(k) record. The listed applicant is Pathwai, Inc.. It received FDA 510(k) clearance on 2026-06-08 under 510(k) number K260332. The device is classified under product code QXO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the EchoNext?

EchoNext is a medical device that received FDA 510(k) clearance on 2026-06-08. The listed applicant is Pathwai, Inc.. The 510(k) number is K260332.

When did EchoNext receive FDA 510(k) clearance?

EchoNext received FDA 510(k) clearance on 2026-06-08, under 510(k) number K260332.

Who is the listed applicant for EchoNext?

The FDA 510(k) record lists Pathwai, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EchoNext?

The FDA product code for EchoNext is QXO.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑